About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Minneapolis | 7,800 Studies Near You

Clinical TrialsMinneapolis

Clinical Trials in Minneapolis

Discover 7,800 clinical trials near Minneapolis, Minnesota. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 861-880 of 7,800 trials

SuspendedArtisan Aphakia Lens for the Correction of Aphakia in ChildrenThe purpose of this study is to determine the safety and effectiveness of the Artisan Aphakia Lens in the treatment of aphakia in children.NCT01547442·Phoenix, Arizona and 18 others CompletedZoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell TransplantRATIONALE: Zoledronic acid, vitamin D, and calcium may prevent bone loss in patients who are undergoing donor stem cell transplant.NCT00321932·Minneapolis, Minnesota and 1 other

Find Trials by Condition in Minneapolis

Breast Cancerin Minneapolis Lung Cancerin Minneapolis Prostate Cancerin Minneapolis Colorectal Cancerin Minneapolis Melanomain Minneapolis Leukemiain Minneapolis Lymphomain Minneapolis Pancreatic Cancerin Minneapolis Ovarian Cancerin Minneapolis Brain Cancerin Minneapolis

Data from ClinicalTrials.govTerms

CompletedRebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple SclerosisThe primary objective of the study is to assess the clinical efficacy of Rebif® 44 microgram (mcg) three times per week compared with Copaxone® 20 milligram (mg) daily in subjects…NCT00078338·Birmingham, Alabama and 79 others

CompletedTesting Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has ProgressedThis phase II trial studies how well cabozantinib s-malate, crizotinib, savolitinib, or sunitinib malate work in treating patients with kidney cancer that has spread from where it…NCT02761057·Anchorage, Alaska and 594 others

CompletedMicra Transcatheter Pacing System Continued Access Study ProtocolMedtronic is sponsoring the Micra Continued Access (CA) study to provide continued access to the Micra System while the marketing application is under review by the Food and Drug…NCT02488681·Los Angeles, California and 28 others

CompletedDecitabine Versus Supportive Care in Adults With Advanced-stage MDSTo compare the safety and efficacy profiles of decitabine to those of supportive care in adults with advanced-stage myelodysplastic syndrome (MDS)NCT00043381·Berkeley, California and 23 others

CompletedA Study of the WallFlex™ Biliary Fully-covered Stent for the Palliative Treatment of Malignant Bile Duct ObstructionThe overall objective of this study is to assess the functionality of the WallFlex™ Biliary Fully-covered stent as a palliative treatment for malignant bile duct obstruction.NCT00433771·San Francisco, California and 9 others

CompletedPharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic FunctionThe primary objective of this study is to evaluate the pharmacokinetic (PK) profile of oral eleclazine and its metabolite, GS-623134, in participants with normal and impaired…NCT02412098·Miami, Florida and 6 others

CompletedProspective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)The goal of this protocol is to establish a cohort of at least 1500 biologic samples collected prospectively from patients treated in BMT CTN centers that will be a shared bio…NCT01879072·Phoenix, Arizona and 41 others

CompletedA Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic EsophagitisThe purpose of this study is to determine whether oral etrasimod is a safe and effective treatment for active eosinophilic esophagitis (EoE) in adult participants.NCT04682639·Birmingham, Alabama and 255 others

CompletedACTIV-6: COVID-19 Study of Repurposed MedicationsThe purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT04885530·Chandler, Arizona and 109 others

CompletedCAFE Comparison of Atypicals in First Episode of PsychosisThe purpose of this study is to compare the effectiveness, tolerability, and efficacy of the currently available atypical antipsychotic drugs olanzapine (2.5-20 mg/day)…NCT00034892·Stanford, California and 25 others

CompletedA Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder CancerThe purpose of this Phase II study is to determine if AZD4877, an experimental drug that is a novel anti-mitotic agent (Eg5 or Kinesin Spindle Protein inhibitor that interferes…NCT00661609·Palo Alto, California and 35 others

CompletedCATIE- Schizophrenia TrialThe CATIE Schizophrenia Trial is part of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project.NCT00014001·Chula Vista, California and 53 others

CompletedAfrezza® INHALE-1 Study in PediatricsINHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the efficacy and safety of Afrezza in combination with a basal insulin (i.e., the Afrezza group) versus…NCT04974528·Los Angeles, California and 38 others

CompletedParavertebral Catheters for Pancreatic SurgeryDesign: Level I randomized prospective outcomes study comparing two groups of patients.NCT02363777·Minneapolis, Minnesota

CompletedObservational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With ExenatideApproximately 30 adults will participate in this study at the International Diabetes Center (IDC). The IDC is the only site conducting this study.NCT00569907·Minneapolis, Minnesota

CompletedIbrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)To evaluate the safety and efficacy of ibrutinib in combination with prednisone in subjects with newly diagnosed moderate to severe cGVHD.NCT02959944·Scottsdale, Arizona and 101 others

TerminatedA Study of K-645 in the Treatment of Multiple Migraine AttacksThis is a multicenter, randomized, double-blind, placebo-controlled, 3-period crossover study to evaluate the safety, tolerability, and efficacy of two dose levels of K-645 in the…NCT07116499·Oceanside, California and 17 others

CompletedVatalanib in Treating Patients With Primary or Secondary Myelodysplastic SyndromesRATIONALE: Vatalanib may be effective in preventing the development of leukemia in patients who have myelodysplastic syndromes.NCT00072475·Lewes, Delaware and 67 others

PreviousPage 44 of 390Next

Diabetes

in Minneapolis

Heart Diseasein Minneapolis